STATIN IS A REASONABLE TREATMENT OPTION FOR PATIENTS WITH POLYSYSTIC OVARY SYNDROME: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Version 2 2024-06-03, 22:23Version 2 2024-06-03, 22:23
Version 1 2022-11-23, 05:28Version 1 2022-11-23, 05:28
conference contribution
posted on 2024-06-03, 22:23 authored by Lan GaoLan Gao, SC LiSTATIN IS A REASONABLE TREATMENT OPTION FOR PATIENTS WITH POLYSYSTIC OVARY SYNDROME: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
History
Volume
15Pagination
A659-A660Publisher DOI
Link to full text
ISSN
1098-3015Language
EnglishPublication classification
E3.1 Extract of paperTitle of proceedings
VALUE IN HEALTHIssue
7Publisher
ELSEVIER SCIENCE INCUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC